scutellarin has been researched along with Diabetic Glomerulosclerosis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Chen, F; Ding, M; Sun, L; Xie, X; Zhu, D | 1 |
Yu, DD; Zhao, H; Zhao, J; Zhi, YJ | 1 |
Qi, XM; Shen, JJ; Wu, YG; Xu, XX; Zhang, P; Zhang, W | 1 |
Kang, SQ; Liu, JY | 1 |
Lin, H; Lin, SY; Qi, XM; Shen, JJ; Wu, GZ; Wu, YG | 1 |
1 review(s) available for scutellarin and Diabetic Glomerulosclerosis
Article | Year |
---|---|
[Efficacy and safety of Breviscapine Injection in treatment of diabetic nephropathy: systematic review and Meta-analysis of randomized controlled trials].
Topics: Diabetic Nephropathies; Drug Therapy, Combination; Flavonoids; Humans; Randomized Controlled Trials as Topic | 2019 |
4 other study(ies) available for scutellarin and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Mice; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Podocytes; Pyroptosis; Rats | 2023 |
Superior renoprotective effects of the combination of breviscapine with enalapril and its mechanism in diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Flavonoids; Kidney; Male; Phytotherapy; Random Allocation; Rats; Rats, Wistar; Transforming Growth Factor beta1 | 2013 |
[Effect of breviscapine on urinary micro-albumine in patients with diabetes mellitus type 2].
Topics: Aged; Albuminuria; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drugs, Chinese Herbal; Female; Flavonoids; Humans; Male; Middle Aged; Phytotherapy | 2003 |
Renoprotective effect of breviscapine through suppression of renal macrophage recruitment in streptozotocin-induced diabetic rats.
Topics: Animals; Chemokine CCL2; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Flavonoids; Intercellular Adhesion Molecule-1; Kidney Glomerulus; Macrophages; Male; Oxidative Stress; Rats | 2006 |